4-Aminopyridine

4-Aminopyridine
Trade Name
Orphan Indication Guillain-Barré syndrome
USA Market Approval USA
USA Designation Date 2005-12-14 00:00:00
Sponsor Acorda Therapeutics, Inc.;420 Saw Mill River Road;Ardsley, New York, 10502